Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Blonde

Showing results (41-50 of 144) with videos related to

Pageof 15
Sort By:
The Diabetes Educator|July 10, 2007
Case presentation: a patient with type 2 diabetesLawrence Blonde, Stuart T Haines, John Jack Leahy, et al.
The Journal of Family Practice|August 24, 2018
From Randomized Controlled Trials to the Real World: Putting Evidence into ContextLawrence Blonde, Jared A Dendy, Neil Skolnik, et al.
Postgraduate Medicine|June 12, 2014
Efficacy and risk of hypoglycemia with use of insulin glargine or comparators in patients with cardiovascular risk factorsLawrence Blonde, Michelle A Baron, Rong Zhou, et al.
Advances in Therapy|February 23, 2021
Translating iGlarLixi Evidence for the Management of Frequent Clinical Scenarios in Type 2 DiabetesNeil Skolnik, Stefano Del Prato, Lawrence Blonde, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 15, 2013
Current issues in GLP-1 receptor agonist therapy for type 2 diabetesZachary T Bloomgarden, Lawrence Blonde, Alan J Garber, et al.
Journal of Managed Care Pharmacy : JMCP|April 11, 2013
New concepts in diabetes: how multihormonal regulation can improve glycemic controlLawrence Blonde, Danial E Baker, Stephen N Davis, et al.
Postgraduate Medicine|March 23, 2016
Effects of canagliflozin on body weight and body composition in patients with type 2 diabetes over 104 weeksLawrence Blonde, Kaj Stenlöf, Albert Fung, et al.
Pharmacotherapy|October 31, 2009
A simulation of the comparative long-term effectiveness of liraglutide and glimepiride monotherapies in patients with type 2 diabetes mellitusSean D Sullivan, Rafael Alfonso-Cristancho, Chris Conner, et al.
Advances in Therapy|October 26, 2018
Interpretation and Impact of Real-World Clinical Data for the Practicing ClinicianLawrence Blonde, Kamlesh Khunti, Stewart B Harris, et al.
Cardiovascular Diabetology|February 28, 2009
Long-term outcomes in patients with type 2 diabetes receiving glimepiride combined with liraglutide or rosiglitazoneSean D Sullivan, Rafael Alfonso-Cristancho, Chris Conner, et al.
Pageof 15

Showing results (41-50 of 144) with videos related to

Sort By:
Pageof 15
The Diabetes Educator|July 10, 2007
Case presentation: a patient with type 2 diabetesLawrence Blonde, Stuart T Haines, John Jack Leahy, et al.
The Journal of Family Practice|August 24, 2018
From Randomized Controlled Trials to the Real World: Putting Evidence into ContextLawrence Blonde, Jared A Dendy, Neil Skolnik, et al.
Postgraduate Medicine|June 12, 2014
Efficacy and risk of hypoglycemia with use of insulin glargine or comparators in patients with cardiovascular risk factorsLawrence Blonde, Michelle A Baron, Rong Zhou, et al.
Advances in Therapy|February 23, 2021
Translating iGlarLixi Evidence for the Management of Frequent Clinical Scenarios in Type 2 DiabetesNeil Skolnik, Stefano Del Prato, Lawrence Blonde, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 15, 2013
Current issues in GLP-1 receptor agonist therapy for type 2 diabetesZachary T Bloomgarden, Lawrence Blonde, Alan J Garber, et al.
Journal of Managed Care Pharmacy : JMCP|April 11, 2013
New concepts in diabetes: how multihormonal regulation can improve glycemic controlLawrence Blonde, Danial E Baker, Stephen N Davis, et al.
Postgraduate Medicine|March 23, 2016
Effects of canagliflozin on body weight and body composition in patients with type 2 diabetes over 104 weeksLawrence Blonde, Kaj Stenlöf, Albert Fung, et al.
Pharmacotherapy|October 31, 2009
A simulation of the comparative long-term effectiveness of liraglutide and glimepiride monotherapies in patients with type 2 diabetes mellitusSean D Sullivan, Rafael Alfonso-Cristancho, Chris Conner, et al.
Advances in Therapy|October 26, 2018
Interpretation and Impact of Real-World Clinical Data for the Practicing ClinicianLawrence Blonde, Kamlesh Khunti, Stewart B Harris, et al.
Cardiovascular Diabetology|February 28, 2009
Long-term outcomes in patients with type 2 diabetes receiving glimepiride combined with liraglutide or rosiglitazoneSean D Sullivan, Rafael Alfonso-Cristancho, Chris Conner, et al.
Pageof 15